Analysis of proline reduction in the nosocomial pathogen Clostridium difficile

Journal of Bacteriology

Volumn 188, Issue 24, 2006, Pages 8487-8495

  Jackson, Sarah ^a   Calos, Mary ^a   Myers, Andrew ^a   Self, William T ^a,b  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b Bldg 20 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GENOMIC DNA; GLYCINE; HYDROXYPROLINE; OXIDOREDUCTASE; PROLINE; PROLINE REDUCTASE; SELENIUM 75; SELENOPROTEIN;

ARTICLE; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SUBSTRATE; FLUOROMETRY; GEL PERMEATION CHROMATOGRAPHY; HOSPITAL INFECTION; ISOTOPE LABELING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION;

AMINO ACID ISOMERASES; AMINO ACID OXIDOREDUCTASES; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; CULTURE MEDIA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GLYCINE; HUMANS; HYDROXYPROLINE; MULTIENZYME COMPLEXES; OXIDATION-REDUCTION; PROLINE; SELENIUM;

CLOSTRIDIUM DIFFICILE;

EID: 33845457071     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.01370-06     Document Type: Article

References (49)

1. Andreesen, J. R., M. Wagner, D. Sonntag, M. Kohlstock, C. Harms, T. Gursinsky, J. Jager, T. Parther, U. Kabisch, A. Grantzdorffer, A. Pich, and B. Sohling. 1999. Various functions of selenols and thiols in anaerobic gram-positive, amino acids-utilizing bacteria. Biofactors 10:263-270.
2. Barker, H. A. 1961. Fermentation of nitrogenous organic compounds, p. 151-188. In I. C. Gunsalus and R. Y. Stanier (ed.), The bacteria, vol. 2. Academic Press, New York, N.Y.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Britz, M. L., and R. G. Wilkinson. 1982. Leucine dissimilation to isovaleric and isocaproic acids by cell suspensions of amino acid fermenting anaerobes: the Stickland reaction revisited. Can. J. Microbiol. 28:291-300.
5. Cases, J., V. Vacchina, A. Napolitano, B. Caporiccio, P. Besancon, R. Lobinski, and J. M. Rouanet. 2001. Selenium from selenium-rich Spirulina is less bioavailable than selenium from sodium selenite and selenomethionine in selenium-deficient rats. J. Nutr. 131:2343-2350.
6. Cone, J. E., R. M. Del Rio, J. N. Davis, and T. C. Stadtman. 1976. Chemical characterization of the selenoprotein component of clostridial glycine reductase: identification of selenocysteine as the organoselenium moiety. Proc. Natl. Acad. Sci. USA 73:2659-2663.
7. Cone, J. E., R. M. del Rio, and T. C. Stadtman. 1977. Clostridial glycine reductase complex. Purification and characterization of the selenoprotein component. J. Biol. Chem. 252:5337-5344.
8. Costilow, R. N. 1977. Selenium requirement for the growth of Ctostridium sporogenes with glycine as the oxidant in Stickland reaction systems. J. Bacteriol. 131:366-368.
9. Eggertson, L. 2004. C. difficile hits Sherbrooke, Que., hospital: 100 deaths. Can. Med. Assoc. J. 171:436.
10. Eggertson, L. 2004. C. difficile: by the numbers. Can. Med. Assoc. J. 171:1331-1332.
11. Eggertson, L., and B. Sibbald. 2004. Hospitals battling outbreaks of C. difficile. Can. Med. Assoc. J. 171:19-21.
12. Fedorko, D. P., and E. C. Williams. 1997. Use of cycloserine-cefoxitin- fructose agar and L-proline-aminopeptidase (PRO Discs) in the rapid identification of Clostridium difficile. J. Clin. Microbiol. 35:1258-1259.
13. Garcia, A., T. Garcia, and J. L. Perez. 1997. Proline-aminopeptidase test for rapid screening of Clostridium difficile. J. Clin. Microbiol. 35:3007.
14. George, W. L., R. D. Rolfe, G. K. Harding, R. Klein, C. W. Putnam, and S. M. Finegold. 1982. Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis. Infection 10:205-208.
15. George, W. L., V. L. Sutler, D. Citron, and S. M. Finegold. 1979. Selective and differential medium for isolation of Clostridium difficile. J. Clin. Microbiol. 9:214-219.
16. Gladyshev, V. N., S. V. Khangulov, and T. C. Stadtman. 1994. Nicotinic acid hydroxylase from Clostridium barkeri: electron paramagnetic resonance studies show that selenium is coordinated with molybdenum in the catalytically active selenium-dependent enzyme. Proc. Natl. Acad. Sci. USA 91:232-236.
17. Graentzdoerffer, A., A. Pich, and J. R. Andreesen. 2001. Molecular analysis of the grd operon coding for genes of the glycine reductase and of the thioredoxin system from Clostridium sticklandii. Arch. Microbiol. 175:8-18.
18. Haslam, S. C., J. M. Ketley, T. J. Mitchell, J. Stephen, D. W. Burdon, and D. C. Candy. 1986. Growth of Clostridium difficile and production of toxins A and B in complex and defined media. J. Med. Microbiol. 21:293-297.
19. Ikeda, D., T. Karasawa, K. Yamakawa, R. Tanaka, M. Namiki, and S. Nakamura. 1998. Effect of isoleucine on toxin production by Clostridium difficile in a defined medium. Zentbl. Bakteriol. 287:375-386.
20. Johnson, S., C. R. Clabots, F. V. Linn, M. M. Olson, L. R. Peterson, and D. N. Gerding. 1990. Nosocomial Clostridium difficile colonisation and disease. Lancet 336:97-100.
21. Kabisch, U. C, A. Grantzdorffer, A. Schierhorn, K. P. Rucknagel, J. R. Andreesen, and A. Pich. 1999. Identification of D-proline reductase from Clostridium sticklandii as a selenoenzyme and indications for a catalytically active pyruvoyl group derived from a cysteine residue by cleavage of a proprotein. J. Biol. Chem. 274:8445-8454.
22. Karasawa, T., S. Ikoma, K. Yamakawa, and S. Nakamura. 1995. A defined growth medium for Clostridium difficile. Microbiology 141:371-375.
23. Karasawa, T., T. Maegawa, T. Nojiri, K. Yamakawa, and S. Nakamura. 1997. Effect of arginine on toxin production by Clostridium difficile in defined medium. Microbiol. Immunol. 41:581-585.
24. Karlsson, S., L. G. Burman, and T. Akerlund. 1999. Suppression of toxin production in Clostridium difficile VP1 10463 by amino acids. Microbiology 145:1683-1693.
25. Kelly, C. P., and J. T. LaMont. 1998. Clostridium difficile infection. Annu. Rev. Med. 49:375-390.
26. Koike, T., M. Kuzuya, T. Asai, S. Kanda, X. W. Cheng, K. Watanabe, Y. Banno, Y. Nozawa, and A. Iguchi. 2000. Activation of MMP-2 by Clostridium difficile toxin B in bovine smooth muscle cells. Biochem. Biophys. Res. Commun. 277:43-46.
27. Loo, V. G., M. D. Libman, M. A. Miller, A. M. Bourgault, C. H. Frenette, M. Kelly, S. Michaud, T. Nguyen, L. Poirier, A. Vibien, R. Horn, P. J. Laflamme, and P. Rene. 2004. Clostridium difficile: a formidable foe. Can. Med. Assoc. J. 171:47-48.
28. Loo, V. G., L. Poirier, M. A. Miller, M. Oughton, M. D. Libman, S. Michaud, A. M. Bourgault, T. Nguyen, C. Frenette, M. Kelly, A. Vibien, P. Brassard, S. Fenn, K. Dewar, T. J. Hudson, R. Horn, P. Rene, Y. Monczak, and A. Dascal. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-2449.
29. Lovitt, R. W., D. B. Kell, and J. G. Morris. 1987. The physiology of Clostridium sporogenes NCIB 8053 growing in defined media. J. Appl. Bacteriol. 62:81-92.
30. Lovitt, R. W., D. B. Kell, and J. G. Morris. 1986. Proline reduction by Clostridium sporogenes is coupled to vectorial proton ejection. FEMS Microbiol. Lett. 36:269-273.
31. Maegawa, T., T. Karasawa, T. Ohta, X. Wang, H. Kato, H. Hayashi, and S. Nakamura. 2002. Linkage between toxin production and purine biosynthesis in Clostridium difficile. J. Med. Microbiol. 51:34-41.
32. McDonald, L. C., G. E. Killgore, A. Thompson, R. C. Owens, Jr., S. V. Kazakova, S. P. Sambol, S. Johnson, and D. N. Gerding. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441.
33. Meyer, M., K. Granderath, and J. R. Andreesen. 1995. Purification and characterization of protein PB of betaine reductase and its relationship to the corresponding proteins glycine reductase and sarcosine reductase from Eubacterium acidaminophilum. Eur. J. Biochem. 234:184-191.
34. Na, X., D. Zhao, H. W. Koon, H. Kim, J. Husmark, M. P. Moyer, C. Pothoulakis, and J. T. LaMont. 2005. Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes. Gastroenterology 128:1002-1011.
35. Nakamura, S., S. Nakashio, K. Yamakawa, N. Tanabe, and S. Nishida. 1982. Carbohydrate fermentation by Clostridium difficile. Microbiol. Immunol. 26:107-111.
36. Osgood, D. P., N. P. Wood, and J. F. Sperry. 1993. Nutritional aspects of cytotoxin production by Clostridium difficile. Appl. Environ. Microbiol. 59:3985-3988.
37. Poilane, I., T. Karjalainen, M. C. Barc, P. Bourlioux, and A. Collignon. 1998. Protease activity of Clostridium difficile strains. Can. J. Microbiol. 44:157-161.
38. Ramshaw, J. A., N. K. Shah, and B. Brodsky. 1998. Gly-X-Y tripeptide frequencies in collagen: a context for host-guest triple-helical peptides. J. Struct. Biol. 122:86-91.
39. Rao, L., B. Puschner, and T. A. Prolla. 2001. Gene expression profiling of low selenium status in the mouse intestine: transcriptional activation of genes linked to DNA damage, cell cycle control and oxidative stress. J. Nutr. 131:3175-3181.
40. Sebaihia, M., B. W. Wren, P. Mullany, N. F. Fairweather, N. Minton, R. Stabler, N. R. Thomson, A. P. Roberts, A. M. Cerdeno-Tarraga, H. Wang, M. T. Holden, A. Wright, C. Churcher, M. A. Quail, S. Baker, N. Bason, K. Brooks, T. Chillingworth, A. Cronin, P. Davis, L. Dowd, A. Fraser, T. Feltwell, Z. Hance, S. Holroyd, K. Jagels, S. Moule, K. Mungall, C. Price, E. Rabbinowitsch, S. Sharp, M. Simmonds, K. Stevens, L. Unwin, S. Whithead, B. Dupuy, G. Dougan, B. Barrell, and J. Parkhill. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786.
41. Seto, B. 1979. Proline reductase: a sensitive fluorometric assay with o-phthal-aldehyde. Anal. Biochem. 95:44-47.
42. Seto, B., and T. C. Stadtman. 1976. Purification and properties of proline reductase from Clostridium sticklandii. J. Biol. Chem. 251:2435-2439.
43. Stadtman, T. C. 1956. Studies on the enzymic reduction of amino acids: a proline reductase of an amino acid-fermenting Clostridium, strain HF. Biochem. J. 62:614-621.
44. Stadtman, T. C., and P. Elliott. 1957. Studies on the enzymic reduction of amino acids. II. Purification and properties of D-proline reductase and a proline racemase from Clostridium sticklandii. J. Biol. Chem. 228:983-997.
45. Stadtman, T. C., and L. S. McClung. 1957. Clostridium sticklandii nov. spec. J. Bacteriol. 73:218-219.
46. Stickland, H. S. 1935. The chemical reactions by which Cl. sporogenes obtains its energy. Biochem. J. 28:1746-1759.
47. Valiquette, L., D. E. Low, J. Pepin, and A, McGeer. 2004. Clostridium difficile infection in hospitals: a brewing storm. Can. Med. Assoc. J. 171:27-29.
48. Warny, M., J. Pepin, A. Fang, G. Killgore, A. Thompson, J. Brazier, E. Frost, and L. C. McDonald. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084.
49. Yamakawa, K., S. Kamiya, X. Q. Meng, T. Karasawa, and S. Nakamura. 1994. Toxin production by Clostridium difficile in a defined medium with limited amino acids. J. Med. Microbiol. 41:319-323.